(CIDRAP News) A British woman living in Florida has what appears to be the first case of variant Creutzfeldt-Jakob disease (vCJD) reported in a US resident, according to the Centers for Disease Control and Prevention (CDC).
(CIDRAP News) It is 13 days since the emergence of a hypothetical smallpox epidemic caused by the release of virus in three US shopping malls. Some 16,000 cases have been reported, 1,000 people have died, and the nation is running out of vaccine. Hospitals are overflowing, and federal and state officials are at odds over how to contain the epidemic.
(CIDRAP News) Data on more than 300,000 proteins that may have potential as treatments for anthraxthe fruits of a project in which thousands of personal computers were used to analyze billions of moleculeshave been turned over to the US and United Kingdom governments.
(CIDRAP News) The US Department of Agriculture (USDA) has set up a new Web site to help food scientists develop and use mathematical models to predict how pathogenic bacteria in food will behave under varying environmental conditions.
(CIDRAP News) British and American scientists have teamed up with several technology corporations in seeking to enlist personal-computer (PC) owners from around the world in the hunt for a molecule that can keep the anthrax toxin out of human cells.
(CIDRAP News) If bioterrorists released smallpox virus today, each person who contracted the disease could infect as many as 10 to 12 more before health authorities would recognize the disease and act to contain it, according to experts writing in the Dec 13 issue of Nature.
(CIDRAP News) A new study commissioned by the US Department of Agriculture (USDA) indicates that the risk of bovine spongiform encephalopathy (BSE) occurring in the United States is extremely low, but USDA officials who released the study said they are considering taking steps to lower the risk further.
Oct 25 (CIDRAP News) Two studies published online by Nature this week help explain how anthrax toxin works, possibly paving the way for the development of drugs that could block the toxin's action. One group of researchers explains how it identified the cell-surface receptor that enables anthrax toxin to invade host cells, while another group describes the precise molecular structure of a key component of the toxin.